Study summary · research use only
Bremelanotide
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This entry describes available information on bremelanotide use during breastfeeding, noting that no clinical data exist on its use in this context. Because bremelanotide is a cyclic peptide molecule with a molecular weight of 1025, the authors state the amount in milk is likely to be very low and that absorption by the infant is unlikely because it is probably destroyed in the infant's gastrointestinal tract. The authors state that, until more data become available, bremelanotide should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. Species: human (clinical information).
Abstract
No information is available on the clinical use of bremelanotide during breastfeeding. Because bremelanotide is a cyclic peptide molecule with a molecular weight of 1025, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. Until more data become available, bremelanotide should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.